NCT04304729

Brief Summary

Type 1 diabetes mellitus (T1D) is the most common form of diabetes among children and youth, and it is increasing around the world, particularly among children under 5 years. This is worrisome given the chronic nature of the disease and its strong association with an increased risk of cardiovascular disease (CVD). Evidence suggests that markers of CVD are already present in children with T1D, making prevention a clinical and public health priority in this high-risk population. Despite this, a good understanding of what factors predispose children with T1D to CVD is still lacking. Our study aims to better understand in this population what individual, familial and environmental characteristics increase the risk for heart disease, how to best measure it early on and what are the potential mechanisms underlying the heightened risk for heart disease in youth with T1D. Specifically, we aim to:

  1. 1.compare established risk factors (dyslipidemia, hypertension) with novel early markers for CVD (cardiac phenotype, arterial stiffness, endothelial function) in adolescents with T1D and healthy controls;
  2. 2.examine the associations between these novel early markers with: i) lifestyle habits; ii) measures of inflammation; and iii) markers of oxidative stress among adolescents with T1D and healthy controls, and determine group differences in these associations;
  3. 3.explore, across both groups, the associations between these established and novel early markers of CVD with neighborhood features.
  4. 4.Determine sex and gender differences in novel markers of CVD (cardiac structure/myocardial oxygenation, vascular studies including endothelial function and arterial stiffness) in youth with T1D and healthy controls;
  5. 5.Determine, across both groups, sex and gender differences in associations between markers of CVD and lifestyle habits, specifically: i) moderate-to-vigorous physical activity (MVPA); ii) dietary intake (carbohydrates, sugar, saturated/trans-fat, fiber, food groups); iii) sedentary behavior; and iv) sleep;
  6. 6.Measure changes in novel markers of CVD from adolescence to early adulthood among individuals with T1D and healthy controls;
  7. 7.Assess whether lifestyle habits in adolescence are prospectively associated with established (dyslipidemia, hypertension) and novel (cardiac structure/myocardial oxygenation, endothelial function, arterial stiffness) markers of CVD in early adulthood, and if these associations differ according to T1D status, adiposity, sex and gender.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
57mo left

Started Jan 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Jan 2017Dec 2030

Study Start

First participant enrolled

January 12, 2017

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

February 27, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 11, 2020

Completed
10.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

December 3, 2024

Status Verified

November 1, 2024

Enrollment Period

14 years

First QC Date

February 27, 2020

Last Update Submit

November 28, 2024

Conditions

Keywords

Type 1 DiabetesCardiovascular diseaseAdolescentsCardiac MRIDietPhysical activitySedentary behaviorSleep

Outcome Measures

Primary Outcomes (3)

  • Cardiac structure (MRI)

    Baseline measurement

  • Endothelial function (Flow-mediated dilation)

    Baseline measurement

  • Vascular structure (Pulse-wave velocity)

    Baseline measurement

Secondary Outcomes (2)

  • Dyslipidemia

    Baseline measurement

  • Hypertension

    Baseline measurement

Study Arms (2)

Diabetics

Girls and boys living with Type 1 Diabetes.

Control

Age and sex matched participants without any type of diabetes

Eligibility Criteria

Age14 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

T1D group: Sainte-Justine Hospital's Diabetes Clinic patients Control group: Community sample

You may qualify if:

  • Diagnosis of T1D (for the T1D group) or no diagnosis of any type of diabetes (for the control group)
  • to 18 years old

You may not qualify if:

  • Youth with another type of diabetes such as T2D
  • Conditions that could limit their ability to participate in the study
  • Known pathology that would influence their risk for CVD
  • Siblings of a participant already enrolled in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Sainte-Justine

Montreal, Quebec, H3T 1C5, Canada

Location

Related Publications (1)

  • Henderson M, Friedrich M, Van Hulst A, Pelletier C, Barnett TA, Benedetti A, Bigras JL, Drapeau V, Lavoie JC, Levy E, Mathieu ME, Nuyt AM. CARDEA study protocol: investigating early markers of cardiovascular disease and their association with lifestyle habits, inflammation and oxidative stress in adolescence using a cross-sectional comparison of adolescents with type 1 diabetes and healthy controls. BMJ Open. 2021 Sep 8;11(9):e046585. doi: 10.1136/bmjopen-2020-046585.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasma, serum, whole blood, urine, feces

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Cardiovascular DiseasesMotor ActivitySedentary Behavior

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Study Officials

  • Mélanie Henderson, MD, Ph.D

    St. Justine's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor, Pediatrics

Study Record Dates

First Submitted

February 27, 2020

First Posted

March 11, 2020

Study Start

January 12, 2017

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Last Updated

December 3, 2024

Record last verified: 2024-11

Locations